In This Section
Search/Filter
Back to Grantees
Loading...
Dr. Carsten Hagemann on AACR-Novocure TTFields Research Grant Impact

Dr. Carsten Hagemann on AACR-Novocure TTFields Research Grant Impact

The AACR-Novocure Tumor Treating Fields Research Grants represent a joint effort to promote and support innovative research focused on Tumor Treating Fields (TTFields), which are intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells. 2020 grant recipient Carsten Hagemann, PhD, shares his perspectives on the myriad benefits of the grant.

AACR Grantee Indicates Novel Mechanism to Enhance Efficacy of Immune Therapies in High Grade Serous Ovarian Cancer

AACR Grantee Indicates Novel Mechanism to Enhance Efficacy of Immune Therapies in High Grade Serous Ovarian Cancer

Despite demonstrated success in many solid tumor types, immune checkpoint blockade (ICB) agents have minimal efficacy in high grade serous ovarian cancer (HGSC). In this study, the authors describe a novel bispecific anti-PD-1/PD-L1 antibody, which showed increased anti-tumor efficacy compared to mono-specific anti-PD-1 or anti-PDL1. The researchers also...